Berit Müller‐Pebody
About
Berit Müller‐Pebody is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, Berit Müller‐Pebody has authored 68 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 25 papers in Applied Microbiology and Biotechnology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Berit Müller‐Pebody's work include Antibiotic Use and Resistance (25 papers), Pneumonia and Respiratory Infections (12 papers) and Neonatal and Maternal Infections (10 papers). Berit Müller‐Pebody is often cited by papers focused on Antibiotic Use and Resistance (25 papers), Pneumonia and Respiratory Infections (12 papers) and Neonatal and Maternal Infections (10 papers). Berit Müller‐Pebody collaborates with scholars based in United Kingdom, United States and India. Berit Müller‐Pebody's co-authors include Alan P. Johnson, Ruth Gilbert, Katherine L. Henderson, Susan Hopkins, Rebecca Guy, Mike Sharland, Katie Harron, Maria Zambon, Harvey Goldstein and Paul T. Heath and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.
In The Last Decade
Berit Müller‐Pebody
64 papers receiving 1.8k citations
Peers
Berit Müller‐Pebody
Eva Melander Sweden
Adriano Dusé South Africa
Chand Wattal India
Akke K. van der Bij Netherlands
Freddie Bwanga Uganda
Neil Gupta United States
Olga Perovic South Africa
Kinh Van Nguyen Vietnam
Mattias Larsson Sweden
Japheth A. Opintan Ghana
Citations per year, relative to Berit Müller‐Pebody Berit Müller‐Pebody (= 1×)
peers
Eva Melander
Countries citing papers authored by Berit Müller‐Pebody
Since
Specialization
Citations
This map shows the geographic impact of Berit Müller‐Pebody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berit Müller‐Pebody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berit Müller‐Pebody more than expected).
Fields of papers citing papers by Berit Müller‐Pebody
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Berit Müller‐Pebody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berit Müller‐Pebody. The network helps show where Berit Müller‐Pebody may publish in the future.
Co-authorship network of co-authors of Berit Müller‐Pebody
This figure shows the co-authorship network connecting the top 25 collaborators of Berit Müller‐Pebody. A scholar is included among the top collaborators of Berit Müller‐Pebody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berit Müller‐Pebody. Berit Müller‐Pebody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Quan, T. Phuong, David W. Eyre, Daniel J. West, et al.. (2025). Timeliness of a potential automated system for national surveillance of healthcare-associated infections in England. Journal of Hospital Infection. 161. 10–12.
2.
Guy, Rebecca, Katie L. Hopkins, Emma Budd, et al.. (2025). The importance of monitoring a new antibiotic: ceftazidime/avibactam usage and resistance experience from England, 2016 to 2020. Eurosurveillance. 30(14).
3.
Borman, Andrew M., Alireza Abdolrasouli, Emma Budd, et al.. (2025). Rapid emergence of Trichophyton indotineae (Trichophyton mentagrophytes ITS genotype VIII) observed in the United Kingdom, up to August 2025. Eurosurveillance. 30(49).
4.
Glover, R. E., Mirza Lalani, Thomas Allen, et al.. (2025). A mixed methods protocol for an impact and implementation evaluation of the Pharmacy First Services for management of common conditions in England. International Journal of Pharmacy Practice. 33(2). 152–161.
5.
Bou-Antoun, Sabine, Alistair Leanord, R.A. Seaton, et al.. (2024). Adaptation of the WHO AWaRe (Access, Watch, Reserve) antibiotic classification to support national antimicrobial stewardship priorities in the UK: findings from a modified Delphi approach to achieve expert consensus. JAC-Antimicrobial Resistance. 7(1). dlae218–dlae218.
6.
Beech, Elizabeth, Colin Brown, Alicia Demirjian, et al.. (2024). Trends in urine sampling rates of general practice patients with suspected lower urinary tract infections in England, 2015–2022: a population-based study. BMJ Open. 14(8). e084485–e084485.
7.
Hammond, Ashley, et al.. (2024). Improving antibiotic prescribing to reduce antimicrobial resistance in UTIs : the IPAP ‐ UTI programme. Prescriber. 35(4). 17–21.
8.
Channon‐Wells, Samuel, Jocelyn Elmes, Berit Müller‐Pebody, et al.. (2023). National point-prevalence survey of healthcare-associated infections and antimicrobial use: UK-PAS/UKHSA joint call to action for all paediatric services. Journal of Antimicrobial Chemotherapy. 78(10). 2392–2394.
9.
Ashiru‐Oredope, Diane, Neil Cunningham, Berit Müller‐Pebody, et al.. (2023). Reporting England’s progress towards the ambitions in the UK action plan for antimicrobial resistance: the English surveillance programme for antimicrobial utilisation and resistance (ESPAUR). Journal of Antimicrobial Chemotherapy. 78(10). 2387–2391.
10.
Stowe, Julia, Elise Tessier, Hongxin Zhao, et al.. (2021). Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design. International Journal of Epidemiology. 50(4). 1124–1133.
11.
Aliabadi, Shirin, Elizabeth Beech, Elita Jauneikaite, et al.. (2021). Effect of antibiotic stewardship interventions in primary care on antimicrobial resistance of Escherichia coli bacteraemia in England (2013–18): a quasi-experimental, ecological, data linkage study. The Lancet Infectious Diseases. 21(12). 1689–1700.
12.
Müller‐Pebody, Berit, et al.. (2020). Monitoring Antimicrobial Resistance and Drug Usage in the Human and Livestock Sector and Foodborne Antimicrobial Resistance in Six European Countries. SHILAP Revista de lepidopterología.
13.
Gilbert, Ruth, Michaela Brown, Rita Faria, et al.. (2020). Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT. Health Technology Assessment. 24(57). 1–190.
14.
Müller‐Pebody, Berit, et al.. (2020). <p>Monitoring Antimicrobial Resistance and Drug Usage in the Human and Livestock Sector and Foodborne Antimicrobial Resistance in Six European Countries</p>. Infection and Drug Resistance. Volume 13. 957–993.
15.
Pouwels, Koen B., Berit Müller‐Pebody, Timo Smieszek, Susan Hopkins, & Julie V. Robotham. (2019). Selection and co-selection of antibiotic resistances among Escherichia coli by antibiotic use in primary care: An ecological analysis. PLoS ONE. 14(6). e0218134–e0218134.
16.
Costelloe, Céire, Susan Hopkins, Alan P. Johnson, et al.. (2018). Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study. International Journal of Antimicrobial Agents. 52(6). 790–798.
17.
Harron, Katie, Harvey Goldstein, Angie Wade, et al.. (2013). Linkage, Evaluation and Analysis of National Electronic Healthcare Data: Application to Providing Enhanced Blood-Stream Infection Surveillance in Paediatric Intensive Care. PLoS ONE. 8(12). e85278–e85278.
18.
Müller‐Pebody, Berit, Alan P. Johnson, Paul T. Heath, et al.. (2010). Empirical treatment of neonatal sepsis: are the current guidelines adequate?. Archives of Disease in Childhood Fetal & Neonatal. 96(1). F4–F8.
19.
Müller‐Pebody, Berit, Mark Muscat, Benjamin Pelle, et al.. (2004). Increase and change in pattern of hospital antimicrobial use, Denmark, 1997–2001. Journal of Antimicrobial Chemotherapy. 54(6). 1122–1126.
20.
Müller‐Pebody, Berit, W. John Edmunds, Maria Zambon, Nigel Gay, & Natasha S. Crowcroft. (2002). Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995–March 1998. Epidemiology and Infection. 129(1). 99–106.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Eva Melander Breakdown of academic impact, for papers by Adriano Dusé Breakdown of academic impact, for papers by Chand Wattal Breakdown of academic impact, for papers by Akke K. van der Bij Breakdown of academic impact, for papers by Freddie Bwanga Breakdown of academic impact, for papers by Neil Gupta Breakdown of academic impact, for papers by Olga Perovic Breakdown of academic impact, for papers by Kinh Van Nguyen Breakdown of academic impact, for papers by Mattias Larsson Breakdown of academic impact, for papers by Japheth A. Opintan